指南与共识腹部技术与安全CTMRUS

印度国家肝脏研究协会与印度放射与影像协会关于肝细胞癌诊断与影像的联合共识声明:纳入肝脏影像报告和数据系统

Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.
指南 / 共识 · J Clin Exp Hepatol · 2019-08-06

该联合共识由印度国家肝脏研究协会与印度放射与影像协会制定,旨在结合LIRADSv2018,为肝细胞癌的影像诊断、采集、解读和报告提供适合印度人群的共同立场。共识指出目前缺乏全球统一的影像诊断指南,并回顾了AASLD、EASL等区域指南及LIRADS的标准化作用。

要点

  • 共识以LIRADSv2018为框架,旨在统一印度肝细胞癌影像的采集、解读与报告。
  • 印度人群与卫生基础设施多样,肝细胞癌影像诊断面临独特挑战。
  • 目前无全球统一肝细胞癌影像诊断指南,存在区域流行病学与移植资格差异。

核心结论

  • 本共识旨在结合LIRADSv2018,在肝细胞癌影像报告与解读上寻求共同立场。

研究设计与样本

  • 由印度国家肝脏研究协会与印度放射与影像协会制定的联合共识声明。
  • 方法为结合LIRADSv2018寻找肝细胞癌影像报告与解读的共同点。
  • 原文未报告共识制定的具体方法学、证据分级及推荐条款。

诊断标准与关键数值

  • 原文未报告具体的敏感度、特异度、AUC、阈值或分级标准数值。

临床应用与阅片要点

  • 原文未据此给出具体的临床推荐或阅片建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular carcinoma (HCC) is the 6th most common cancer and the second most common cause of cancer-related mortality worldwide. There are currently no universally accepted practice guidelines for the diagnosis of HCC on imaging owing to the regional differences in epidemiology, target population, diagnostic imaging modalities, and staging and transplant eligibility. Currently available regional and national guidelines include those from the American Association for the Study of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL), the Asian Pacific Association for the Study of the Liver, the Japan Society of Hepatology, the Korean Liver Cancer Study Group, Hong Kong, and the National Comprehensive Cancer Network in the United States. India with its large population and a diverse health infrastructure faces challenges unique to its population in diagnosing HCC. Recently, American Association have introduced a Liver Imaging Reporting and Data System (LIRADS, version 2017, 2018) as an attempt to standardize the acquisition, interpretation, and reporting of liver lesions on imaging and hence improve the coherence between radiologists and clinicians and provide guidance for the management of HCC. The aim of the present consensus was to find a common ground in reporting and interpreting liver lesions pertaining to HCC on imaging keeping LIRADSv2018 in mind.

来源:J Clin Exp Hepatol,查看原文。版权归原作者所有。

引用

  1. Krishan S, Dhiman RK, Kalra N, et al. Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System. J Clin Exp Hepatol. 2019. PMID: 31695253. doi:10.1016/j.jceh.2019.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。